Neoplasms by Histologic Type  >>  oxaliplatin  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT02244489: Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma

Terminated
1b
16
US
Momelotinib (MMB), GS-0387, CYT387, Capecitabine, Oxaliplatin
Sierra Oncology, Inc.
Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma
03/17
04/17
NCT00220649: Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas

Completed
1
25
US
gemcitabine; irinotecan; leucovorin; 5-fluorouracil; oxaliplatin
St. Luke's-Roosevelt Hospital Center, Sanofi
Pancreatic Neoplasms
 
 
NCT01764477: Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Completed
1
20
US
PRI-724
Prism Pharma Co., Ltd., inVentiv Health Clinical
Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma
10/15
10/15

Download Options